Allarity Therapeutics Inc (ALLR) Stock Price

0.9777 ▲ +0.1073 (+12.33%)
Open: 0.8735 Vol: 166.75K Day's range: 0.8735 - 1.03 Nov 02, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ALLR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.99▼ 0.94▲ 0.94▲ 0.92▲ 0.92▲
MA10 0.96▲ 0.91▲ 0.91▲ 0.90▲ 1.05▼
MA20 0.92▲ 0.91▲ 0.92▲ 0.91▲ 1.17▼
MA50 0.92▲ 0.90▲ 0.89▲ 1.09▼ 1.20▼
MA100 0.90▲ 0.93▲ 0.95▲ 1.19▼ 1.16▼
MA200 0.99▼ 1.06▼ 1.13▼ 1.22▼ 9,811.35▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.011▲ 0.009▲ 0.008▲ 0.019▲ 0.066▲
RSI 59.625▲ 63.060▲ 61.256▲ 51.957▲ 31.917▼
STOCH 87.886▲ 89.657▲ 66.475     66.481     16.574▼
WILL %R -30.139     -30.139     -30.139     -22.739▲ -76.307▼
CCI 63.343     202.960▲ 158.027▲ 176.363▲ -66.063    
Latest Filters Detected On ALLR
▲ RSI&VOL $ALLR RSI Cross Up and Volume Set Alert
RSI $ALLR RSI(14) Crossed Above 50 Set Alert
MA $ALLR Price Crossed Above MA(26) Set Alert
MA $ALLR Price Crossed Above MA(13) Set Alert
MA $ALLR Price Crossed Above MA(7) Set Alert
▲ BREAK $ALLR Price Breaks 10 Days High Set Alert
Allarity Therapeutics Inc News
Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue
Friday, October 30, 2026 04:45 AM
Agreement complements revenue from standard gene expression and DRP® services - Development and validation services will support a European biotechnology company’s precision oncology predictive device ...
Allstate (NYSE:ALL) Rate Discipline Comes Back Into Focus
Tuesday, October 06, 2026 02:06 AM
Allstate (NYSE:ALL) is in focus as auto insurance pricing and homeowners margins shape the outlook. Explore the key themes and milestones to watch next.
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
Wednesday, September 30, 2026 05:00 AM
Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and ...
ALLR historical stock data
date open high low close volume
02/11/26 0.8735 1.03 0.8735 0.9777 166,751
30/10/26 0.89 0.9046 0.85 0.8704 165,196
29/10/26 0.915 0.938 0.854 0.89 150,036
28/10/26 0.93 0.9594 0.91 0.95 69,802
27/10/26 0.93 0.96 0.90 0.92 135,554
26/10/26 0.8727 0.9575 0.87 0.9151 174,219
23/10/26 0.842 0.896 0.84 0.865 71,100
22/10/26 0.8799 0.8799 0.8246 0.8466 76,711
21/10/26 0.8732 0.9023 0.84 0.8796 88,643
20/10/26 0.8899 0.9075 0.8701 0.8758 108,498
Quote Details
52wk Low:0.769
52wk High:1.84
Vol:166.75K
Avg Vol(3m):1.8M
1Y Chng:-14.24%
1M Chng:-11.92%
Add to Watch List
More Information
Index US Composite
Market Cap. 13.85M